Related Experiment Videos

Potential use of D-glucaric acid derivatives in cancer prevention

Z Walaszek1

  • 1Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Smithville 78957.

Cancer Letters
|October 8, 1990
PubMed

Insights

D-glucaric acid and its derivatives show promise in controlling cancer development. Supplementation may reduce cancer risk in humans by inhibiting key enzymes involved in the carcinogenic process.

Area of Science:

  • Biochemistry
  • Oncology
  • Nutritional Science

Background:

  • Growing evidence suggests beta-glucuronidase inhibitors can control carcinogenesis.
  • D-glucaric acid is a natural, non-toxic compound found in mammals, some fruits, and vegetables.
  • D-glucaro-1,4-lactone and D-glucarates possess in vivo antiproliferative properties.

Purpose of the Study:

  • To explore the potential of D-glucaro-1,4-lactone and D-glucarates in cancer chemoprevention.
  • To evaluate the role of D-glucaric acid and its derivatives in inhibiting carcinogenic processes.

Main Methods:

  • Review of animal model studies on beta-glucuronidase inhibitors.
  • Analysis of the antiproliferative effects of D-glucaro-1,4-lactone and D-glucarates.
  • Investigation of D-glucaric acid's natural occurrence and bioavailability.

Main Results:

  • Animal models indicate D-glucaro-1,4-lactone and D-glucarates can inhibit stages of carcinogenesis.
  • These compounds exhibit significant antiproliferative activity in vivo.
  • D-glucaric acid is a naturally occurring substance with potential dietary or supplemental chemopreventive benefits.

Conclusions:

  • D-glucaric acid and its derivatives represent a potential strategy for cancer risk reduction.
  • Dietary intake of D-glucaric acid-rich foods or D-glucarate supplementation may offer chemopreventive effects.
  • Further research into human subpopulations and combination therapies is warranted.

Related Concept Videos